Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bushen Huatan Decoction (BSHTD) is a Traditional Chinese Medicine (TCM) herbal formula primarily used for the treatment of Polycystic Ovarian Syndrome (PCOS), specifically the subtype characterized by kidney deficiency and phlegm-dampness. The formula is designed to tonify the kidney Qi and resolve metabolic phlegm to restore endocrine balance and improve insulin sensitivity. It typically consists of a complex mixture of herbs, including *Cuscuta chinensis*, *Rehmannia glutinosa*, *Poria cocos*, and *Morinda officinalis*. Clinical research, largely conducted in China, evaluates BSHTD as a standalone therapy or in combination with Western pharmaceuticals like metformin and lifestyle interventions such as Baduanjin exercise to manage insulin resistance and reproductive dysfunction in PCOS patients.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Bushen Huatan Decoction.